Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Rossignol

Showing results (1-10 of 541) with videos related to

Pageof 55
Sort By:
JACC. Heart Failure|October 10, 2021
A Step Forward Toward a New Treatment Paradigm in the Cardiorenal ContinuumPatrick Rossignol
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrologyPatrick Rossignol
Nephrologie & Therapeutique|March 15, 2016
[Carotid barostimulation in the treatment of resistant hypertension]Patrick Rossignol
Nephrology News & Issues|June 4, 2016
Heart failure with reduced ejection fraction. Hyperkalemia and worsening renal function as challenges to implementation (guidelines vs real-world)Patrick Rossignol
Nephrologie & Therapeutique|May 17, 2021
[Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study]Patrick Rossignol,
European Journal of Heart Failure|February 22, 2022
Is it time to shift our focus from treatment to prevention of heart failure with a mineralocorticoid receptor antagonist?Patrick Rossignol, Bertram Pitt
European Journal of Heart Failure|June 10, 2024
When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failureBertram Pitt, Patrick Rossignol
Circulation|October 26, 2018
Cardiorenal Syndrome RevisitedFaiez Zannad, Patrick Rossignol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2021
Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?Patrick Rossignol, Rajiv Agarwal
Journal of the American College of Cardiology|November 5, 2013
Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysisBertram Pitt, Patrick Rossignol
Pageof 55

Showing results (1-10 of 541) with videos related to

Sort By:
Pageof 55
JACC. Heart Failure|October 10, 2021
A Step Forward Toward a New Treatment Paradigm in the Cardiorenal ContinuumPatrick Rossignol
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
A new area for the management of hyperkalaemia with potassium binders: clinical use in nephrologyPatrick Rossignol
Nephrologie & Therapeutique|March 15, 2016
[Carotid barostimulation in the treatment of resistant hypertension]Patrick Rossignol
Nephrology News & Issues|June 4, 2016
Heart failure with reduced ejection fraction. Hyperkalemia and worsening renal function as challenges to implementation (guidelines vs real-world)Patrick Rossignol
Nephrologie & Therapeutique|May 17, 2021
[Recurrent hyperkalaemia management and use of renin-angiotensin-aldosterone system inhibitors: Analysis of French data from the PROKALE multinational European study]Patrick Rossignol,
European Journal of Heart Failure|February 22, 2022
Is it time to shift our focus from treatment to prevention of heart failure with a mineralocorticoid receptor antagonist?Patrick Rossignol, Bertram Pitt
European Journal of Heart Failure|June 10, 2024
When chronic kidney disease (CKD) intersects with heart failure: Insights and implications of the identification of KDIGO-defined CKD in 1.4 million U.S. Veterans with heart failureBertram Pitt, Patrick Rossignol
Circulation|October 26, 2018
Cardiorenal Syndrome RevisitedFaiez Zannad, Patrick Rossignol
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 7, 2021
Should renin-angiotensin-aldosterone system inhibition enablement be a therapeutic target in CKD patients?Patrick Rossignol, Rajiv Agarwal
Journal of the American College of Cardiology|November 5, 2013
Mineralocorticoid receptor antagonists in patients with end-stage renal disease on chronic hemodialysisBertram Pitt, Patrick Rossignol
Pageof 55